These results indicate that suppression of the TXNIP-NLRP3 inflammasome pathway is required for SalA to ameliorate hepatic inflammation and oxidative stress during HFD-induced NAFLD. The gene discussed is TXNIP; the disease is metabolic dysfunction-associated steatotic liver disease.